PAVmed Q4 EPS $(0.15) Beats $(0.25) Estimate, Sales $112.00K Miss $270.00K Estimate
PAVmed Q4 EPS $(0.15) Beats $(0.25) Estimate, Sales $112.00K Miss $270.00K Estimate
PAVmed (NASDAQ:PAVM) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.25) by 40 percent. This is unchanged from the same period last year. The company reported quarterly sales of $112.00 thousand which missed the analyst consensus estimate of $270.00 thousand by 58.52 percent. This is a 62.67 percent decrease over sales of $300.00 thousand the same period last year.
PAVmed (NASDAQ:PAVM) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.25) by 40 percent. This is unchanged from the same period last year. The company reported quarterly sales of $112.00 thousand which missed the analyst consensus estimate of $270.00 thousand by 58.52 percent. This is a 62.67 percent decrease over sales of $300.00 thousand the same period last year.
PAVMED（納斯達克：PAVM）報告了每股美元（0.15）的季度虧損，超過了分析師共識估計（0.25）的 40 百分比。這與去年同期不變。該公司報告的季度銷售額為 112.00 萬美元，錯過了分析師的共識估計為 270.00 萬美元，通過了 58.52 百分比。與去年同期相比，這是一個 62.67 百分比下降了 300.00 萬美元的銷售額。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧